Warning Letter

The following Warning Letter dated November 22, 2013, was sent to Ann Wojcicki, CEO of 23andMe, Inc., regarding the marking of the 23andMe Saliva Collection Kit and Personal Genome Service without marketing clearance and approval in violation of the Federal Food, Drug and Cosmetic Act. I’ve left off the address, which you can find on […]

Continue reading about 23andMe gets Warning Letter from U.S. Food and Drug Administration (FDA)